Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cancer Immunol Res. 2020 Mar 11;8(5):660–671. doi: 10.1158/2326-6066.CIR-19-0552

Figure 2. Effects of blocking IL1α and/or IL1β on tumor growth.

Figure 2.

2×105 EL-4 cells were injected i.d. into mice. (A) WT mice were treated with anti-IL1β, anti-IL1α or both 2 days before and then every 2–3 days after tumor cell injection. Mice injected with control Ab were used as controls (n=5–6 mice per group). (B) IL1R1−/− mice and IL1α−/− mice were treated with anti-IL1β or control Ab 2 days before and then every 2–3 days after tumor cell injection (n=5–8 mice per group). (C) IL1β−/− mice were treated with anti-IL1α or control Ab. Tumor size and survival was recorded every 2–3 days and plotted (n=5–8 mice per group). Statistics were generated compared to IL1β−/− mice with control Ab. Graphs show mean ± SEM. *P<0.05, **P<0.01, ***P<0.001. NS=not significant.